{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-017864","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2022-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.271198+00:00","generated_at":"2026-06-24T23:09:19.241497+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Oncotelic issues $335K convertible note to Blue Lake Partners as part of $1M financing","bullets":["Issued $335,000 convertible promissory note to Blue Lake Partners, LLC at 12% interest.","Note matures in one year; convertible into common stock at $0.10 per share.","Issued 3,025,000 warrants to purchase common stock at $0.20 per share.","Financing part of cumulative $1M raise via JH Darbie; $605K from Mast Hill in May 2022.","Proceeds for general working capital; not for insider loans or illegal purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-017864","json":"https://secwatch.observer/filing/0001493152-22-017864.json","markdown":"https://secwatch.observer/filing/0001493152-22-017864.md","text":"https://secwatch.observer/filing/0001493152-22-017864.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315222017864/0001493152-22-017864-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315222017864/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:09:19.241497+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}